Blunted adrenocorticotropin and increased adrenal steroid response to human corticotropin-releasing hormone in Alzheimer's disease

Biological Psychiatry

Volumn 39, Issue 5, 1996, Pages 311-318

  Näsman, Birgitta ^a   Olsson, Tommy ^a   Fagerlund, Markku ^b   Eriksson, Sture ^a   Viitanen, Matti ^b   Carlström, Kjell ^b  

^a UMEÅ UNIVERSITY HOSPITAL   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

ACTH; Adrenal androgens; Alzheimer's disease; Corticotropin releasing hormone; Cortisol; Hippocampus

Indexed keywords

ANDROSTENEDIONE; CORTICOTROPIN; CORTICOTROPIN RELEASING FACTOR; HYDROCORTISONE; PRASTERONE;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HORMONE BLOOD LEVEL; HORMONE RELEASE; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; INTRAVENOUS DRUG ADMINISTRATION; MALE; PRIORITY JOURNAL; REGULATORY MECHANISM;

EID: 2542510433     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/0006-3223(95)00173-5     Document Type: Article

References (48)

1. Amsterdam JD, Marinelli DL, Arger P, Winokur A (1987): Assessment of adrenal gland volume by computed tomography in depressed patients and healthy volunteers: a pilot study. Psychiatry Res 21:189-197.
2. Antoni FA (1993): Vasopressinergic control of pituitary adrenocorticotropin secretion comes of age. Front Neuroendocrinol 14:76-122.
3. Behan DP, Potter E, Sutton S, Fischer W, Lowry PJ, Vale WW (1993): Corticotropin-releasing factor-binding protein. Ann N Y Acad Sci 697:1-8.
4. Brody S, Carlström K, Lagrelius A, Lunell N-O, Rosenborg L (1983): Serum levels of 4-androstene-3,17-dione in menstruating and postmenopausal women. Acta Obstet Gynecol Scand 62:531-534.
5. Carlström K, Brody S, Lunell N-O, et al (1988): Dehydroepiandrosterone sulphate and dehydroepiandrosterone in serum: differences related to age and sex. Maturitas 10:297-306.
6. Charlton, BG (1990): Adrenal cortical innervation and glucocorticoid secretion. J Endocrinology 126:5-8.
7. Coyle JT, Price DL, DeLong MR (1983): Alzheimer's disease: a disorder of cortical cholinergic innervation. Science 219: 1184-1190.
8. Davis KL, Davis BM, Greenwald BS, et al (1986): Cortisol and Alzheimer's disease, I: basal studies. Am J Psychiatry 143: 300-305.
9. De Leon MJ, McRae T, Tsai JR, et al (1988): Abnormal cortisol response in Alzheimer's disease linked to hippocampal atrophy. Lancet 2:391-392.
10. De Souza EB, Whitehouse PJ, Kuhar MJ, Price DL, Vale WW (1986): Reciprocal changes in corticotropin releasing factor-like immunoreactivity and CRF receptors in cerebral cortex of Alzheimer's disease. Nature 319:593-595.
11. De Souza EB, Whitehouse PJ, Price DL, Vale WW (1987): Abnormalities in corticotropin-releasing hormone (CRH) in Alzheimer's disease and other human disorders. Ann N Y Acad Sci 512:237-247.
12. Dodt C, Dittmann J, Hruby J, et al (1991): Different regulation of adrenocorticotropin and cortisol secretion in young, mentally healthy elderly and patients with senile dementia of Alzheimer's type. J Clin Endocrinol Metab 72:272-276.
13. Folstein MF, Folstein SE, McHugh PR (1975): 'Mini-Mental State': a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12:189-198.
14. Gold PW, Loriaux DL, Roy A, et al (1986a): Responses to corticotropin-releasing hormone in the hypercortisolism of depression and Cushing's disease. N Engl J Med 314:1329-1335.
15. Gold PW, Gwirtsman H, Avgerinos PC, et al (1986b): Abnormal hypothalamic-pituitary-adrenal function in anorexia nervosa: pathophysiologic mechanisms in underweight and weight-corrected patients. N Engl J Med 314:1335-1342.
16. Greenspan SL, Rowe JW, Maitland LA, McAloon-Dyke M, Elahi D (1993): The pituitary-adrenal glucocorticoid response is altered by gender and disease J Gerontol 48:M72-M77.
17. Greenwald BS, Mathě AA, Mohs RC, Levy MI, Johns CA, Davis KL (1986): Cortisol and Alzheimer's disease, II: Dexamethasone suppression, dementia severity, and affective symptoms. Am J Psychiatry 143:442-446.
18. Hachinski VC, Iliff LD, Phil M, et al (1975): Cerebral blood flow in dementia. Arch Neurol 32:632-637.
19. Heuser IJ, Juncos JL, Gold PW (1989): Neuroendocrine functions in Alzheimer's disease patients. J Neural Transm Park Dis Dement Sect 1:76.
20. Hughes CP, Berg L, Danziger WL, Coben LA, Martin RL (1982): A new clinical scale for the staging of dementia. Br J Psychiatry 140:566-572.
21. Hyman BT, Van Hoesen GW, Damasio AR, Barnes CL (1984): Alzheimer's disease: cell-specific pathology isolates the hippocampal formation. Science 225:1168-1170.
22. Jacobson L, Sapolsky R (1991): The role of the hippocampus in feedback regulation of the hypothalamic-pituitary-adrenocortical axis. Endocrinol Rev 12:118-134.
23. Leblhuber F, Windhager E, Steinparz FX, Dienstl E, Reisecker F, Rittmannsberger H (1991): Dehydroepiandrosterone-sulfate serum levels in normal aging and Alzheimer's disease. Age 14:116-118.
24. Lesch KP, Ihl R, Frölich L, et al (1990): Endocrine responses to growth hormone releasing hormone and corticotropin releasing hormone in early-onset Alzheimer's disease. Psychiatry Res 33:107-112.
25. Maeda K, Tanimoto K, Terada T, Shintani T, Kakigi T (1991): Elevated urinary free cortisol in patients with dementia. Neurobiol Aging 12:161-163.
26. Mandell A, Chapman LF, Rand RW, Walter RD (1963): Plasma corticosteroids: changes in concentration after stimulation of hippocampus and amygdala. Science 139:1212.
27. Martignoni E, Petraglia F, Costa A, Bono G, Genazzani AR, Nappi G (1990): Dementia of the Alzheimer type and hypothalamus-pituitary-adrenocortical axis: changes in cerebrospinal fluid corticotropin releasing factor and plasma cortisol levels. Acta Neurol Scand 81:452-456.
28. Martin JB, Reichlin S (1987): Clinical Neuroendocrinology, 2nd ed. Philadelphia: FA Davis Company, pp 175-176.
29. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM (1984): Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group. Neurology 34:939-944.
30. Molchan SE, Hill JL, Mellow AM, Lawlor BA, Martinez R, Sunderland T (1990): The dexamethasone suppression test in Alzheimer's disease and major depression: relationship to dementia severity, depression, and CSF monoamines. Int Psychogeriatr 2:99-122.
31. Montgomery SA, Åsberg M (1979): A new depression scale designed to be sensitive to change. Br J Psychiatry 134:382-389.
32. Murphy DGM, DeCarli CD, Daly E, et al (1993): Volumetric magnetic resonance imaging in men with dementia of the Alzheimer type: correlations with disease severity. Biol Psychiatry 34:612-621.
33. Nemeroff CB, Krishnan KRR, Reed D, Leder D, Beam C, Dunnick NR (1992): Adrenal gland enlargement in major depression: a computed tomographic study. Arch Gen Psychiatry 49:384-387.
34. Näsman B, Olsson T, Bäckström T, et al (1991): Serum dehydroepiandrosterone sulfate in Alzheimer's disease and in multi-infarct dementia. Biol Psychiatry 30:684-690.
35. Näsman B, Olsson T, Viitanen M, Carlström K (1995): A subtle disturbance in the feedback regulation of the hypothalamic-pituitary-adrenal axis in the early phase of Alzheimer's disease. Psychoneuroendocrinology 20:211-220.
36. Orth DN, Kovacs WJ, DeBold CR (1992): The adrenal cortex. In Wilson JD and Foster DW (eds), Williams Textbook of Endocrinology. Philadelphia: WB Saunders Co, pp 489-620.
37. Roelfsema F, Van Den Berg G, Frölich M, et al (1993): Sex-dependent alteration in cortisol response to endogenous adrenocorticotropin. J Clin Endocrinol Metab 77:234-240.
38. Roy-Byrne PP, Uhde TW, Post RM, Gallucci W, Chrousos GP, Gold PW (1986): The corticotropin-releasing hormone stimulation test in patients with panic disorder. Am J Psychiatry 143:896-899.
39. Sapolsky RM (1992): Stress, the Aging Brain, and the Mechanisms of Neuron Death. Cambridge: MIT Press.
40. Sapolsky RM, Krey LC, McEwen BS (1986): The neuroendocrinology of stress and aging: the glucocorticoid cascade hypothesis. Endocrinol Rev 7:284-301.
41. Skare S, Pew B, Dysken M (1990): The dexamethasone suppression test in dementia: a review of the literature. J Geriatr Psychiatry Neurol 3:124-138.
42. Stege R, Eriksson A, Henriksson P, Carlström K (1987): Orchidectomy or oestrogen treatment in prostatic cancer: effects on serum levels of adrenal androgens and related steroids. Int J Androl 10:581-587.
43. Sunderland T, Merril CR, Harrington MG, et al (1989): Reduced plasma dehydroepiandrosterone concentrations in Alzheimer's disease. Lancet 2:570.
44. Van Hoesen GW, Hyman BT (1990): Hippocampal formation: anatomy and the patterns of pathology in Alzheimer's disease. Prog Brain Res 83:445-457.
45. Wahlund LO, Andersson-Lundman G, Basun H, et al (1993): Cognitive functions and brain structures: a quantitative study of CSF volumes on Alzheimer patients and healthy control subjects. Magn Reson Imaging 11:169-174.
46. Welsch K, Butters N, Hughes JP, Mohs RC, Heyman A (1992): Detecting and staging of dementia in Alzheimer's disease: Use for the neuropsychological measures developed for the Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Arch Neurol 49:448-452.
47. Wick G, Hu Y, Schwarz S, Kroemer G (1993): Immunoendocrine communication via the hypothalamo-pituitary-adrenal axis in autoimmune diseases. Endocrinol Rev 14:539-563.
48. Wilkinson L (1988): SYSTAT: The System for Statistics, Evanston, IL: SYSTAT Inc.